STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,630 | -2.6% | 72,241 | +162.8% | 0.00% | – |
| Q2 2023 | $292,187 | +126.0% | 27,487 | +77.1% | 0.00% | – |
| Q1 2023 | $129,298 | -57.3% | 15,522 | +7.7% | 0.00% | – |
| Q1 2022 | $303,000 | -77.5% | 14,409 | -74.4% | 0.00% | – |
| Q4 2021 | $1,348,000 | +5.3% | 56,180 | +11.6% | 0.00% | – |
| Q3 2021 | $1,280,000 | -22.0% | 50,348 | +3.3% | 0.00% | – |
| Q2 2021 | $1,641,000 | -10.2% | 48,742 | +3.5% | 0.00% | – |
| Q1 2021 | $1,828,000 | -40.2% | 47,073 | -4.7% | 0.00% | – |
| Q4 2020 | $3,058,000 | +295.6% | 49,382 | +114.1% | 0.00% | – |
| Q3 2020 | $773,000 | +126.7% | 23,067 | +61.3% | 0.00% | – |
| Q2 2020 | $341,000 | +15.6% | 14,300 | +11.2% | 0.00% | – |
| Q1 2020 | $295,000 | – | 12,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |